Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2026-01-27 @ 6:08 AM
Study NCT ID:
NCT06383468
Status:
RECRUITING
Last Update Posted:
2024-04-25
First Post:
2024-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
Sponsor:
Akeso
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-01-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-21
First Submit QC Date:
None
Study First Post Date:
2024-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-21
Last Update Post Date:
2024-04-25
Last Update Post Date Type:
ACTUAL